KUALA LUMPUR: Sunzen Biotech Bhd’s renounceable rights issue was oversubscribed by 14.06% at the close of acceptance on Feb 22.
The animal health specialist company said it raised RM44.8mil from the rights issue which would be used to expand its business.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!